Metronomic Chemotherapy Combined With Bevacizumab and Erlotinib in Patients With Metastatic HER2-Negative Breast Cancer: Clinical and Biological Activity
Titel:
Metronomic Chemotherapy Combined With Bevacizumab and Erlotinib in Patients With Metastatic HER2-Negative Breast Cancer: Clinical and Biological Activity
Auteur:
Montagna, Emilia Cancello, Giuseppe Bagnardi, Vincenzo Pastrello, Davide Dellapasqua, Silvia Perri, Gino Viale, Giuseppe Veronesi, Paolo Luini, Alberto Intra, Mattia Calleri, Angelica Rampinelli, Cristiano Goldhirsch, Aron Bertolini, Francesco Colleoni, Marco